Tech Company Financing Transactions
Freenome Funding Round
Freenome, based in San Francisco, scored $290 million in funding from Roche Venture Fund.
Transaction Overview
Company Name
Announced On
1/19/2022
Transaction Type
Venture Equity
Amount
$290,000,000
Round
Undisclosed
Investors
Roche Venture Fund (Thomas Schinecker)
Proceeds Purpose
This investment will be an important step to advance early cancer screening, and we look forward to joining Freenome in this journey.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
279 East Grand Ave. 5th Floor
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Undisclosed
Website
Email Address
Overview
Freenome is the dynamic collection of genetic material floating in your blood (cell-free) derived from the trillions of cells in your body. It is your living cell-free genome changing over time and space.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gabriel Otte
Chief Financial Officer
William Quirk
Chief Medical Officer
Girish Putcha
Chief Operating Officer
Riley Ennis
Chief Scientific Officer
Jimmy Lin
VP - Bus. Development
Michael Nolan
VP - Client Services
Charles Roberts
Browse more venture capital transactions:
Prev: 1/19/2022: Azibo venture capital transaction
Next: 1/19/2022: BondCliQ venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs